Brief: Ensysce Biosciences - On January 27, Co Received Notice In Form Of Deficiency Letter From Nasdaq - Filing
Jan 31 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES INC - ON JANUARY 27, CO RECEIVED
NOTICE IN
FORM OF DEFICIENCY LETTER FROM NASDAQ
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing